Analytic for Hemodynamic Instability (AHI) vs AHI System

When considering AI tools for early detection of hemodynamic instability, physicians might encounter two offerings from Fifth Eye: the Analytic for Hemodynamic Instability (AHI) and the AHI System. Both are FDA-cleared, AI-powered Software as a Medical Device (SaMD) solutions designed to provide real-time predictive analytics by continuously monitoring adult in-hospital patients using ECG Lead II data. Their core function is to offer early warnings of hemodynamic instability, potentially hours before traditional vital signs indicate deterioration, aiming to reduce nurse surveillance burden and streamline workflow.

The key practical difference appears to be in their emphasis and stated capabilities. While both predict hemodynamic instability, the Analytic for Hemodynamic Instability (AHI) specifically highlights its ability to predict up to 26 hours ahead for AHI-PI and provides easy-to-interpret visual indicators (red, yellow, green). The AHI System, on the other hand, emphasizes its role in optimizing hospital resources and enhancing clinical decision-making. Physicians primarily seeking the earliest possible warning with clear visual cues for proactive intervention might lean towards the Analytic for Hemodynamic Instability (AHI). Those prioritizing a system that also explicitly supports resource optimization and broader clinical decision enhancement may find the AHI System more aligned with their needs.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist